Now I have a thorough understanding of the paper and all reviewer claims. Let me produce the consolidated review.

---

## Summary

BenchMol is a unified benchmarking platform for molecular representation learning (MRL) that integrates seven molecular modalities (fingerprint, sequence, graph, geometry, image, geometry image, video) within a single codebase. The paper introduces two new benchmarks — MBANet (molecular basic attributes across 12 atoms, 4 bonds, 8 attributes) and StructNet (preference across 6 molecule types from ChEMBL 34) — and reports results from over 57,000 controlled model-training runs under consistent settings, yielding nine findings about modality-specific strengths.

## Strengths

1. **First unified platform integrating 7 molecular modalities.** BenchMol is the first MRL platform to support fingerprint, sequence, graph, geometry, image, geometry image, and video modalities in a single framework. Prior benchmarks (OGB, Geom3D, MOLGRAPHEVAL) each cover only one or two modalities. *Evidence: Abstract, Section 1 ("first MRL platform supporting different modalities"), Section 4.1, Table 1.*

2. **Two novel benchmarks systematically probing modality strengths.** MBANet tests molecular basic attributes (atoms, bonds, basic properties) and StructNet tests preferences across 6 molecule types (acyclic, cyclic, macrocyclic, reticular, etc.), going substantially beyond standard MoleculeNet property prediction. *Evidence: Section 4.2, Figure 2, description of 60 datasets in StructNet.*

3. **Large-scale controlled experiment with 57,060 models under a consistent protocol.** The paper enforces identical hyperparameter search ranges, repeated 10× with seeds 0–9, and consistent scaffold splits. This directly addresses the unfair comparison problem identified in Section 1. *Evidence: Section 5.1 (settings), Tables 2–6, the claim "at least 57,060 models" in Contributions.*

4. **Extensive modality extractor and model coverage.** The platform provides 44 fingerprint extractors, 2 sequence tokenizers, 2 graph featurizers, 7 geometry featurizers, and integration with timm (900+ vision models), enabling broad and flexible benchmarking. *Evidence: Section 4.3 (modality extractors), Section 4.4 (model initializer).*

5. **Actionable findings about modality preferences.** The paper reports 9 specific findings (e.g., video modality excels at atomic/attribute tasks, geometry prefers acyclic molecules, vision-based modalities prefer macrocyclic/reticular molecules) that provide practical guidance for researchers. *Evidence: Findings 5, 6, 8, 9 (Sections 5.3, 5.4), Tables 5, 6.*

6. **Simple API lowering usability barrier.** The platform can be used with only 4 lines of code, making it easily adoptable. *Evidence: Section 4.7.*

## Weaknesses

### Fatal
None.

### Major
None.

### Minor

1. **StructNet target variable type is not explicitly stated.** The paper describes StructNet as "molecular activity datasets" and evaluates them with RMSE (regression). ChEMBL activity data is predominantly continuous (pIC50, Ki, etc.), making RMSE a standard choice. However, the paper does not explicitly state whether the targets are continuous activity values or binarized labels, which would affect the interpretation of RMSE. Adding one sentence clarifying the label type in Section 4.2 or 5.1 would resolve this. *Evidence: Section 4.2 (lines 70–71), Section 5.1 (line 136).*

2. **The caption of Table 6 does not mention variance, creating ambiguity.** The paper's methodology (Section 5.1) states that all experiments repeat 10 times with seeds 0–9 and report "mean and standard variance." However, the caption of Table 6 reads "average RMSE performance" without referencing standard deviations. If the actual table (an embedded image) does contain standard deviations alongside the averages, the caption should say so to avoid confusion. If it does not, the variance information is missing from the paper's most important result table, which would weaken Findings 8 and 9. The authors should clarify this in the caption. *Evidence: Section 5.1 (lines 130–131), Table 6 caption (lines 300–301).*

3. **The MBANet atom-counting analysis (Finding 5) could be strengthened with a simple sanity check.** The paper claims video modalities outperform graph models at atom-counting tasks. Finding 6 provides a plausible explanation (graph message passing increases similarity of different atom types) supported by cosine similarity analysis (Figure 4a). However, the paper does not test a trivial baseline — e.g., linear regression directly on one-hot atom-type input features — which would clarify whether the GIN-R failure is an optimization issue or a genuine modality limitation. Adding this sanity check would make the finding more robust. *Evidence: Section 5.3, Findings 5 and 6 (lines 288–293), Table 5, Figure 4a.*

4. **The DBI comparison in Finding 7 lacks statistical grounding.** The paper reports DBI values of 2.57 (video) vs. 4.69 (graph) for clustering quality but does not provide confidence intervals, significance tests, or repeated runs to establish whether this difference is reliable. *Evidence: Section 5.3, Finding 7 (line 294).*

### Trivial

1. **Missing computational cost reporting.** The paper does not report total GPU-hours or approximate runtime per model/task, which would help users assess practical trade-offs when adopting different modalities.

## Nice-to-Haves

- A simple linear-readout baseline on one-hot atom-type features for the MBANet atom-counting task, to distinguish optimization issues from genuine modality limitations (related to Minor Weakness 3 above).
- A time-to-first-result measurement (e.g., time from API import to evaluating one model on one dataset) to quantify the usability claim.

## Removed Points

These points were raised by reviewers but are removed after verification against the paper:

- **"StructNet metric is inappropriate for binary labels" (Harsh Critic, Critical Issue #1):** The critic speculated the labels might be binary and RMSE inappropriate. The paper says "molecular activity datasets" from ChEMBL 34; ChEMBL activity data is standardly continuous (pIC50, Ki, etc.). The paper clearly treats StructNet as regression with RMSE. The critic's concern is speculative and not supported by the paper's description. The issue is retained as Minor Weakness #1 (clarity) but removed as a critical concern.

- **"Table 6 missing variance" treated as critical:** The paper's methodology explicitly states "report the mean and standard variance" for ALL experiments including StructNet. Whether Table 6 actually contains standard deviations cannot be verified from the text (table is an image), but the paper's stated methodology claims consistency. Retained as Minor Weakness #2 (caption ambiguity) rather than a critical omission.

- **"Atom-counting result is counterintuitive and needs stronger support" treated as critical:** The paper provides a concrete analysis (Finding 6, Figure 4a) with cosine similarity evidence that graph message passing makes atom representations less discriminative. The critic's suggestion to add a linear baseline is a reasonable enhancement but does not invalidate the existing analysis. Retained as Minor Weakness #3.

- **Generic area-of-concern sweeps:** Claims about "evaluation lacks rigor," "baselines may not be fair," and similar framing without concrete anchors in the paper are removed.

- **Missing appendix references or proofs:** These sections are stripped by the PDF parser and exist in the original submission.

## Novel Insights

None beyond the paper's own contributions. The core novel insight — that different molecular modalities have systematic preferences (e.g., video for atomic tasks, geometry for acyclic molecules, vision-based modalities for macrocyclic/reticular molecules) — is the paper's own contribution, confirmed by the controlled experiments.

## Suggestions

1. In Section 4.2 or 5.1, add one sentence explicitly stating whether StructNet targets are continuous (e.g., pIC50) or binarized, and cite the relevant ChEMBL assay endpoint type.
2. In the Table 6 caption, explicitly state whether values are "average RMSE ± standard deviation over 10 seeds" (matching the stated methodology in Section 5.1).
3. For the MBANet atom-counting analysis, add a simple baseline: linear regression on one-hot atom-type histograms. Report whether this oracle baseline achieves near-zero error, to validate whether the task is genuinely solvable from input features.
4. Add a brief computational cost table (GPU-hours per model type, approximate runtime per dataset) to help practitioners assess practical trade-offs.

## Score and Decision

The paper's contribution is substantial and well-supported. It addresses a genuine need for unified, fair evaluation across molecular representation modalities, validated through a large-scale controlled experimental campaign (≥57,060 runs). The methodological weaknesses are minor presentation/clarity gaps rather than fatal flaws. The three issues identified (StructNet target clarity, Table 6 caption ambiguity, MBANet sanity check) are all easily addressable and do not undermine the paper's core claims.

Originality: High — first multi-modality platform integrating 7 modalities.
Importance: High — addresses fragmented evaluation in a growing field.
Claims supported: Mostly yes, with minor clarity gaps.
Soundness: Strong — controlled setting with consistent splits, seeds, hyperparameters.
Writing: Clear and well-structured.
Value to community: High — open-source platform with practical usability.

MY FINAL SCORE: <score>8.0</score>
MY FINAL DECISION: <decision>Accept</decision>